WSC
IBB icon

Wellington Shields & Co’s iShares Biotechnology ETF IBB Stock Holding History

Wellington Shields & Co’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$245K Buy
1,290
+390
+43% +$67K 0.06% 236
2026
Q1 		$152K Hold
900
– – 0.04% 253
2025
Q4 		$152K Buy
+900
New +$146K 0.04% 257
2025
Q1 		– Sell
-900
Closed -$119K – 313
2024
Q4 		$119K Sell
900
-700
-44% -$98.4K 0.04% 238
2024
Q3 		$233K Hold
1,600
– – 0.07% 204
2024
Q2 		$220K Hold
1,600
– – 0.07% 199
2024
Q1 		$220K Buy
+1,600
New +$219K 0.07% 200
2023
Q1 		– Sell
-1,258
Closed -$165K – 304
2022
Q4 		$165K Buy
1,258
+358
+40% +$46.3K 0.04% 216
2022
Q3 		$105K Hold
900
– – 0.05% 224
2022
Q2 		$106K Buy
+900
New +$107K 0.03% 229
2019
Q3 		– Sell
-2,017
Closed -$220K – 150
2019
Q2 		$220K Sell
2,017
-274
-12% -$29.1K 0.1% 156
2019
Q1 		$256K Sell
2,291
-270
-11% -$29.6K 0.13% 138
2018
Q4 		$247K Sell
2,561
-300
-10% -$31.8K 0.14% 132
2018
Q3 		$349K Buy
2,861
+1
+0% +$118 0.19% 102
2018
Q2 		$314K Buy
+2,860
New +$306K 0.16% 110
2018
Q1 		– Sell
-2,340
Closed -$250K – 151
2017
Q4 		$250K Buy
+2,340
New +$250K 0.13% 131

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Wellington Shields & Co's IBB Position: Q2 2026 in Review

Wellington Shields & Co increased its iShares Biotechnology ETF (IBB) stake by 43% in Q2 2026, buying an estimated $67K and bringing the position to 1,290 shares worth $245K. The position accounts for 0.06% of the portfolio, ranked #236.

Wellington Shields & Co first reported a position in IBB in Q4 2017 and has held it in 16 quarters since. The position peaked at $349K in Q3 2018. 954 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • Wellington Shields & Co held 1,290 shares of iShares Biotechnology ETF worth $245K as of Q2 2026.
  • Wellington Shields & Co bought 390 iShares Biotechnology ETF shares in Q2 2026, an estimated $67K.
  • iShares Biotechnology ETF made up 0.06% of Wellington Shields & Co's portfolio in Q2 2026, its #236 holding.
  • Wellington Shields & Co first reported a position in iShares Biotechnology ETF in Q4 2017 and has held it in 16 quarters since.
  • Wellington Shields & Co's iShares Biotechnology ETF position peaked at $349K in Q3 2018.
  • 954 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Wellington Shields & Co's 13F filing for Q2 2026, filed 10 Aug 2026.